GSK plc (LON: GSK, NYSE: GSK), a leading pharmaceutical company based in the UK, has announced the appointment of Li Weidong to the role of Vice President and Head of Vaccine Business for GSK China. Li will report directly to Sherman Yu, GSK Vice President and General Manager of GSK China.
Li Weidong holds a degree in Facial Medicine from Harbin Medical University and brings with him over 25 years of experience in the pharmaceutical industry, with more than 14 years specifically in the field of vaccines. Throughout his career, he has worked with major industry players such as Xi’an Janssen, Sanofi Pasteur, and Pfizer. Prior to joining GSK, Li served as the Deputy General Manager and Head of Operations at WestVac Biopharma, after having been the Vaccine Market Access Director for Pfizer’s China division. – Fineline.com
